Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Purple Biotech Ltd. (PPBT)

July 12, 2024 8:19 AM EDT Send to a Friend
H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $10.00 price target on Purple Biotech Ltd. (NASDAQ: PPBT).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login